The dynamics of HER2-low expression during breast cancer progression

被引：0
|
作者：
Sarah Anderson
Brooke Baxter Bartow
Gene P. Siegal
Xiao Huang
Shi Wei
机构：
[1] The University of Alabama at Birmingham,Department of Pathology
[2] The University of Kansas Medical Center,Department of Pathology and Laboratory Medicine
来源：
Breast Cancer Research and Treatment | 2023年 / 201卷
关键词：
Breast cancer; HER2-low; Immunohistochemistry; In situ hybridization; Amplification; Overexpression;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：437 / 446
页数：9
相关论文
共 50 条
  • [1] The dynamics of HER2-low expression during breast cancer progression
    Anderson, Sarah
    Bartow, Brooke Baxter
    Siegal, Gene P.
    Huang, Xiao
    Wei, Shi
    BREAST CANCER RESEARCH AND TREATMENT, 2023, 201 (03) : 437 - 446
  • [2] The Dynamic of HER2-low Expression during Breast Cancer Progression
    Anderson, Sarah
    Bartow, Brooke
    Huang, Xiao
    Wei, Shi
    LABORATORY INVESTIGATION, 2023, 103 (03) : S89 - S89
  • [3] Dynamics of HER2-low expression in triple-negative breast cancer
    Garrido-Castro, Ana C.
    Ngo, Lan D.
    Richardson, Edward T.
    Frangieh, Allison
    Mohammed-Abreu, Ayesha
    Hughes, Melissa E.
    Zanudo, Jorge Gomez Tejada
    Navarro, John
    Tarantino, Paolo
    Mittendorf, Elizabeth A.
    Tolaney, Sara
    King, Tari
    Winer, Eric
    Lin, Nancy U.
    Wagle, Nikhil
    CANCER RESEARCH, 2023, 83 (05)
  • [4] HER2-Low expression in primary male breast cancer
    Rudlowski, Christian
    Erices-Leclercq, Melanie
    Nobbe, Katleen
    Baldus, Stephan
    Foerster, Robert
    Foerster, Frank
    Lubig, Sabine
    ONCOLOGY RESEARCH AND TREATMENT, 2024, 47 : 29 - 29
  • [5] Alteration of HER2 Status During Breast Cancer Progression: A Clinicopathological Analysis Focusing on HER2-Low Status
    Bai, Kyungah
    Woo, Ji Won
    Kwon, Hyun Jung
    Chung, Yul Ri
    Suh, Koung Jin
    Kim, Se Hyun
    Kim, Jee Hyun
    Park, So Yeon
    LABORATORY INVESTIGATION, 2024, 104 (08)
  • [6] ERBB2 mRNA expression in HER2-low breast cancer
    Teng, X.
    Li, X.
    Xu, S.
    Zhang, J.
    Bai, Y.
    Ba, X.
    Wu, Z.
    Liu, S.
    EUROPEAN JOURNAL OF CANCER, 2022, 175 : S93 - S93
  • [7] Study of HER2-low expression in triple-negative breast cancer
    Trung, T. Tran
    Ngoc, A. Duong Thi
    Van, T. Nguyen
    Van, T. Ta
    BREAST, 2025, 80
  • [8] Effect of HER2-low expression on neoadjuvant efficacy in operable breast cancer
    Yi, Xiaoli
    Hu, Shasha
    Ma, Meili
    Huang, Dongshuai
    Zhang, Yan
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2024, 26 (04): : 880 - 890
  • [9] Trastuzumab Deruxtecan in HER2-Low Breast Cancer
    Carroll, Hailey K.
    Higgins, Michaela J.
    O'Reilly, Seamus
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (12): : 1144 - 1144
  • [10] Evolution of HER2-low expression from primary to recurrent breast cancer
    Miglietta, Federica
    Griguolo, Gaia
    Bottosso, Michele
    Giarratano, Tommaso
    Lo Mele, Marcello
    Fassan, Matteo
    Cacciatore, Matilde
    Genovesi, Elisa
    De Bartolo, Debora
    Vernaci, Grazia
    Amato, Ottavia
    Conte, PierFranco
    Guarneri, Valentina
    Dieci, Maria Vittoria
    NPJ BREAST CANCER, 2021, 7 (01)
12345